[Italy] AI in Lung Cancer Screening: Clinical Practice and Perspectives in Italy

Italy at the Threshold of a National Program

Lung cancer remains the leading cause of cancer death in Italy, with over 41,500 new cases and 33,800 deaths reported in 2018. Five-year survival is only about 16%.
While Italy does not yet have an official national lung cancer screening program, the RISP (Italian Lung Screening Network) is rapidly expanding as a large-scale pilot.
Launched in 2021, RISP involves 18 hospitals across the country, enrolling 10,000 high-risk individuals for free LDCT (low-dose CT) screening. More than 8,000 participants have already undergone baseline scans. Cost-effectiveness studies have confirmed the value of LDCT, paving the way for possible nationwide adoption.

Register Now (Free Registration)
Pre-register today to receive the webinar link and presentation materials in advance.

Webinar Overview

• Title: Screening del Cancro Polmonare con l’Intelligenza Artificiale – Clinical Practice and Perspectives in Italy
• Date: Wednesday, October 15, 2025 – 5 pm (CET)
• Format: Virtual Webinar (60 minutes, in Italian)
• Speaker: 
  Prof. Nicola Sverzellati (University Hospital of Parma)
  Prof. Mario Silva (University of Parma)
• Moderator: Prof. Stefano Palmucci (University of Catania)
• Audience: Radiologists, pulmonologists, hospital leaders, and healthcare stakeholders

Agenda

1. Introduction (5 min)

• Welcome, current status of lung cancer screening in Italy
• Moderator: Prof. Stefano Palmucci (University of Catania)

2. Session 1 (15 min)

• Speaker: Prof. Nicola Sverzellati (University Hospital of Parma)
• Topic: “LCS ora in Italia – Lung Cancer Screening in Italy Today”

3. Session 2 (25 min)

• Speaker: Prof. Mario Silva (University Hospital of Parma)
• Topic: “Clinical Practice: Lung Nodules – Characteristics, Guidelines, and Findings”

4. Conclusion & Future Perspectives (10 min)

• Q&A Session (10–15 min)

 

Speaker & Moderator

•  Moderator: 

Prof. Stefano Palmucci
Department of Medical Surgical Sciences and Advanced Technologies, University of Catania
Pulmonary Imaging & Advanced Radiological Technologies Unit

 

• Speakers: 

Prof. Nicola Sverzellati
Prof. of Radiology & Director of Diagnostic Dept., University Hospital of Parma

Prof. Mario Silva

MD, PhD, Radiologist, Dept. of Medicine and Surgery, University Hospital of Parma

Why This Webinar Matters

1. Italy’s Current Status
While there is no nationwide screening yet, pilot programs such as RISP are laying the groundwork.

2. Clinical Practice Insights
Attendees will learn how lung nodules are managed in daily practice, how guidelines are applied, and how AI supports radiologists in interpretation.

3. Global Perspective
Experts from Italy, Europe, and Korea will share experiences and discuss strategies for advancing lung cancer screening.

 

Registration Information

Register here to secure your spot.
Registered participants will receive the webinar link, presentation slides, and access to the replay video after the event.

This webinar is a must-attend opportunity for radiologists, pulmonologists, healthcare leaders, and policymakers interested in the future of lung cancer screening in Italy.
Join Coreline Soft and leading Italian experts to explore how AI can redefine patient-centered radiology and screening programs.